The amyloid-β precursor protein (APP) helps to form links between the brain’s neurons. It has been highly studied because its ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...

Once breakthroughs in brain imaging accurately quantified amyloid plaques and tau tangles, they could finally prove that experimental agents actually removed amyloid and lowered tau. And contrary ...

This treatment reduced the brain levels of the characteristic amyloid plaques associated with Alzheimer’s due to the activation of microglia, immune cells in the brain that clear the plaque.